These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
606 related articles for article (PubMed ID: 21081242)
1. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort. Baur DM; Klotsche J; Hamnvik OP; Sievers C; Pieper L; Wittchen HU; Stalla GK; Schmid RM; Kales SN; Mantzoros CS Metabolism; 2011 Oct; 60(10):1363-71. PubMed ID: 21081242 [TBL] [Abstract][Full Text] [Related]
2. Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients. Bo S; Ciccone G; Rosato R; Villois P; Appendino G; Ghigo E; Grassi G Diabetes Obes Metab; 2012 Jan; 14(1):23-9. PubMed ID: 21812892 [TBL] [Abstract][Full Text] [Related]
3. Relation between diabetes, metformin treatment and the occurrence of malignancies in a Belgian primary care setting. Geraldine N; Marc A; Carla T; Chantal M; Stefaan B; Welcome W; Frank B Diabetes Res Clin Pract; 2012 Aug; 97(2):331-6. PubMed ID: 22386769 [TBL] [Abstract][Full Text] [Related]
4. Risk of malignancies in patients with insulin-treated diabetes mellitus: results of a population-based trial with 10-year follow-up (JEVIN). Schiel R; Müller UA; Braun A; Stein G; Kath R Eur J Med Res; 2005 Aug; 10(8):339-44. PubMed ID: 16131475 [TBL] [Abstract][Full Text] [Related]
5. Mortality in type 2 diabetic subjects prescribed metformin and sulphonylurea drugs in combination: cohort study. Gulliford M; Latinovic R Diabetes Metab Res Rev; 2004; 20(3):239-45. PubMed ID: 15133756 [TBL] [Abstract][Full Text] [Related]
6. Impact of glycaemic control, hypertension and insulin treatment on general and cause-specific mortality: an Italian population-based cohort of type II (non-insulin-dependent) diabetes mellitus. Bruno G; Merletti F; Boffetta P; Cavallo-Perin P; Bargero G; Gallone G; Pagano G Diabetologia; 1999 Mar; 42(3):297-301. PubMed ID: 10096781 [TBL] [Abstract][Full Text] [Related]
7. Vertebral fractures in males with type 2 diabetes treated with rosiglitazone. Mancini T; Mazziotti G; Doga M; Carpinteri R; Simetovic N; Vescovi PP; Giustina A Bone; 2009 Oct; 45(4):784-8. PubMed ID: 19527806 [TBL] [Abstract][Full Text] [Related]
8. [Prevalence and pharmacotherapy of diabetes mellitus in primary care]. Lehnert H; Wittchen HU; Pittrow D; Bramlage P; Kirch W; Böhler S; Höfler M; Ritz E Dtsch Med Wochenschr; 2005 Feb; 130(7):323-8. PubMed ID: 15712019 [TBL] [Abstract][Full Text] [Related]
9. Diabetes mellitus and increased risk of cancer: focus on metformin and the insulin analogs. McFarland MS; Cripps R Pharmacotherapy; 2010 Nov; 30(11):1159-78. PubMed ID: 20973689 [TBL] [Abstract][Full Text] [Related]
10. Sulphonylureas and cancer: a case-control study. Monami M; Lamanna C; Balzi D; Marchionni N; Mannucci E Acta Diabetol; 2009 Dec; 46(4):279-84. PubMed ID: 19082520 [TBL] [Abstract][Full Text] [Related]
11. [Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners]. Fabian W; Majkowska L; Stefański A; Moleda P Przegl Lek; 2005; 62(4):201-5. PubMed ID: 16229234 [TBL] [Abstract][Full Text] [Related]
12. Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study. Schramm TK; Gislason GH; Vaag A; Rasmussen JN; Folke F; Hansen ML; Fosbøl EL; Køber L; Norgaard ML; Madsen M; Hansen PR; Torp-Pedersen C Eur Heart J; 2011 Aug; 32(15):1900-8. PubMed ID: 21471135 [TBL] [Abstract][Full Text] [Related]
14. The joint effects of different types of glucose-lowering treatment and duration of diabetes on total and cardiovascular mortality among subjects with type 2 diabetes. Khalangot M; Tronko M; Kravchenko V; Kulchinska J; Hu G Diabetes Res Clin Pract; 2008 Oct; 82(1):139-47. PubMed ID: 18703252 [TBL] [Abstract][Full Text] [Related]
15. Age, renal dysfunction, cardiovascular disease, and antihyperglycemic treatment in type 2 diabetes mellitus: findings from the Renal Insufficiency and Cardiovascular Events Italian Multicenter Study. Solini A; Penno G; Bonora E; Fondelli C; Orsi E; Trevisan R; Vedovato M; Cavalot F; Cignarelli M; Morano S; Ferrannini E; Pugliese G; J Am Geriatr Soc; 2013 Aug; 61(8):1253-61. PubMed ID: 23889588 [TBL] [Abstract][Full Text] [Related]
16. Association between congestive heart failure and hospitalization in patients with type 2 diabetes mellitus receiving treatment with insulin or pioglitazone: a retrospective data analysis. Rajagopalan R; Rosenson RS; Fernandes AW; Khan M; Murray FT Clin Ther; 2004 Sep; 26(9):1400-10. PubMed ID: 15531002 [TBL] [Abstract][Full Text] [Related]
17. A comparison of select cardiovascular outcomes by antidiabetic prescription drug classes used to treat type 2 diabetes among Military Health System beneficiaries, fiscal year 2003-2006. Casscells SW; Granger E; Swedorske J; Goldhammer R; Shaheen M; Dorris J; Hong A; Wiktor M Am J Ther; 2008; 15(3):198-205. PubMed ID: 18496256 [TBL] [Abstract][Full Text] [Related]
18. Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort. Dehal AN; Newton CC; Jacobs EJ; Patel AV; Gapstur SM; Campbell PT J Clin Oncol; 2012 Jan; 30(1):53-9. PubMed ID: 22124092 [TBL] [Abstract][Full Text] [Related]
19. Cancer risk in diabetic patients treated with insulin glargine? Prescrire Int; 2010 Aug; 19(108):162-3. PubMed ID: 20939447 [TBL] [Abstract][Full Text] [Related]
20. Baseline characteristic differences between patients prescribed sitagliptin vs. other oral antihyperglycemic agents: analysis of a US electronic medical record database. Zhang Q; Rajagopalan S; Mavros P; Engel SS; Davies MJ; Yin D; Radican L Curr Med Res Opin; 2010 Jul; 26(7):1697-703. PubMed ID: 20465367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]